Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
US9289439B2 · kind B2 · utility
1Cited by
2References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2014 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Jun 29, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of reducing hepatocellular damage in a subject using a water-soluble cocrystal composition which contains a quantity of acetylsalicylic acid and a quantity of a theanine enantiomer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.